NPY modulates epinephrine-induced leukocytosis via Y-1 and Y-5 receptor activation in vivo:: sympathetic co-transmission during leukocyte mobilization

被引:37
作者
Bedoui, S
Lechner, S
Gebhardt, T
Nave, H
Beck-Sickinger, AG
Straub, RH
Pabst, R
von Hörsten, S
机构
[1] Hannover Med Sch, Dept Funct & Appl Anat, D-30625 Hannover, Germany
[2] Hannover Med Sch, Dept Gastroenterol & Hepatol, D-30625 Hannover, Germany
[3] Univ Leipzig, Dept Biochem, D-04103 Leipzig, Germany
[4] Univ Hosp, Dept Internal Med 1, D-93042 Regensburg, Germany
关键词
neuropeptide Y; epinephrine; co-transmission; leukocytosis; male lewis rats; in vivo catheterization;
D O I
10.1016/S0165-5728(02)00278-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Sympathetic nervous system (SNS) activation mobilizes blood leukocytes. Under these circumstances, both epinephrine (EPI) and neuropeptide Y (NPY) are released. Therefore, we investigated a possible interaction between these transmitters during leukocyte mobilization, using intravenous catheterization of male adult Lewis rats. Intravenous application of NPY followed by EPI, dose-dependently facilitated, intensified and inhibited EPI-induced leukocytosis with subset-specificity for NK-cells, monocytes, and B-lymphocytes. Pharmacological assessment of NPY receptors involved revealed a Y-1R-mediated inhibition and a Y-5R-mediated facilitation. RT-PCR on peripheral blood mononuclear cells (PBMC) detected Y-1R mRNA only, suggesting direct Y-1R-mediated effects on leukocytes and indirect effects via the Y-5R. Thus, via a specific Y-1R/Y-5R interplay, NPY acts as a neuroimmune co-transmitter in vivo. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:25 / 33
页数:9
相关论文
共 35 条
[1]   Differential effects of neuropeptide Y (NPY) on leukocyte subsets in the blood:: mobilization of B-1-like B-lymphocytes and activated monocytes [J].
Bedoui, S ;
Kuhlmann, S ;
Nave, H ;
Drube, J ;
Pabst, R ;
von Hörsten, S .
JOURNAL OF NEUROIMMUNOLOGY, 2001, 117 (1-2) :125-132
[2]   Catecholamine-induced leukocytosis: Early observations, current research, and future directions [J].
Benschop, RJ ;
RodriguezFeuerhahn, M ;
Schedlowski, M .
BRAIN BEHAVIOR AND IMMUNITY, 1996, 10 (02) :77-91
[3]   The first selective agonist for the neuropeptide YY5 receptor increases food intake in rats [J].
Cabrele, C ;
Langer, M ;
Bader, R ;
Wieland, HA ;
Doods, HN ;
Zerbe, O ;
Beck-Sickinger, AG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (46) :36043-36048
[4]   Effect of neuropeptide Y on inflammatory paw edema in the rat:: involvement of peripheral NPYY1 and Y5 receptors and interaction with dipeptidyl-peptidase IV (CD26) [J].
Dimitrijevic, M ;
Stanojevic, S ;
Vujic, V ;
Kovacevic-Jovanovic, V ;
Beck-Sickinger, A ;
Demuth, HU ;
von Hörsten, S .
JOURNAL OF NEUROIMMUNOLOGY, 2002, 129 (1-2) :35-42
[5]   Neural immunoregulation: emerging roles for nerves in immune homeostasis and disease [J].
Downing, JEG ;
Miyan, JA .
IMMUNOLOGY TODAY, 2000, 21 (06) :281-289
[6]  
DRUBE J, 1999, IMMUNOBIOLOGY, V200, P686
[7]   NEUROPEPTIDE-Y CO-EXISTS AND CO-OPERATES WITH NORADRENALINE IN PERIVASCULAR NERVE-FIBERS [J].
EKBLAD, E ;
EDVINSSON, L ;
WAHLESTEDT, C ;
UDDMAN, R ;
HAKANSON, R ;
SUNDLER, F .
REGULATORY PEPTIDES, 1984, 8 (03) :225-235
[8]  
Elenkov IJ, 2000, PHARMACOL REV, V52, P595
[9]   NEUROPEPTIDE-Y INHIBITS IN-VIVO SPECIFIC ANTIBODY-PRODUCTION IN RATS [J].
FRIEDMAN, EM ;
IRWIN, MR ;
NONOGAKI, K .
BRAIN BEHAVIOR AND IMMUNITY, 1995, 9 (03) :182-189
[10]  
HARADA Y, 1992, J NEUROCHEM, V59, P2178